Susquehanna International Group’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Susquehanna International Group’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-37,392	Closed	-$16.2K	–	13583
2023 Q1	$16.2K	Buy	+37,392	New	+$28.7K	﹤0.01%	12098
2022 Q4	–	Sell	-22,017	Closed	-$51K	–	14214
2022 Q3	$51K	Buy	22,017 +5,404	+33%	+$14.1K	﹤0.01%	12193
2022 Q2	$37K	Buy	+16,613	New	+$115K	﹤0.01%	12137

Other funds holding GRNA

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CGC

Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

Susquehanna International Group's GRNA Position: Q2 2023 in Review

Susquehanna International Group sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q2 2023, closing a stake of 37,392 shares — an estimated $16.2K sold.

Susquehanna International Group first reported a position in GRNA in Q2 2022 and held it in 3 quarters. The position peaked at $51K in Q3 2022. 48 funds tracked by Wall St. Rank hold GRNA as of Q2 2023.

Susquehanna International Group reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q2 2023 after selling out during the quarter.
Susquehanna International Group sold 37,392 GreenLight Biosciences Holdings, PBC Common Stock shares in Q2 2023, an estimated $16.2K.
Susquehanna International Group first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2022 and held it in 3 quarters.
Susquehanna International Group's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $51K in Q3 2022.
48 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.